chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Neck pain, Pain, Pain in extremity
Clinical narrative: My arm was sore; My body started to get achy/ body aches; I continued to have abdominal pain all night; Back of neck pain; I projectile vomited four times; stooled myself following diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 27May2021 at 15:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included sinusitis and abdominal pain. The patient was unknown about known allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27May2021 at 18:30, a few hours after getting 1st vaccine, the patient experienced body started to get achy and the patient had abdominal pain that got worst. She projectile vomited four times and stooled herself following diarrhea. She was able to make it to the bathroom but it was a mess and she had to shower. Then she continued to have abdominal pain all night. She used ice packs on her stomach and back of neck to help with the pain. She had never experienced anything like this before. Also, before getting her vaccine she was hydrated, had no alcohol for a week, ate well, did not eat anything that she had not eaten before, was well rested, and even had a nice non stressful day before the injection. 16 hours later her arm was sore and body aches. She was hoping to have no more symptoms and she was very hesitant to get the second shot. She was never diagnosed with COVID but if she did have it her body did not make her sick and the shot did. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of body started to get achy/ body aches, abdominal pain, back of neck pain, vomited four times, diarrhea and sore were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: My arm was sore; My body started to get achy/ body aches; I continued to have abdominal pain all night; Back of neck pain; I projectile vomited four times; stooled myself following diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 27May2021 at 15:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included sinusitis and abdominal pain. The patient was unknown about known allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27May2021 at 18:30, a few hours after getting 1st vaccine, the patient experienced body started to get achy and the patient had abdominal pain that got worst. She projectile vomited four times and stooled herself following diarrhea. She was able to make it to the bathroom but it was a mess and she had to shower. Then she continued to have abdominal pain all night. She used ice packs on her stomach and back of neck to help with the pain. She had never experienced anything like this before. Also, before getting her vaccine she was hydrated, had no alcohol for a week, ate well, did not eat anything that she had not eaten before, was well rested, and even had a nice non stressful day before the injection. 16 hours later her arm was sore and body aches. She was hoping to have no more symptoms and she was very hesitant to get the second shot. She was never diagnosed with COVID but if she did have it her body did not make her sick and the shot did. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcomes of body started to get achy/ body aches, abdominal pain, back of neck pain, vomited four times, diarrhea and sore were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash papulosquamous
Clinical narrative: 2 days after vaccine developed a papulosquamous patch on chest. Within the next several days it was scattered papulosquamous rash on chest and back. Very pruritic.; Very pruritic.; This is a spontaneous report from a contactable physician. A 17-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18May2021 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021, the patient experienced a papulosquamous patch on chest within the next several days it was scattered papulosquamous rash on chest and back, very pruritic. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL and steroid cream. The clinical outcome of the events papulosquamous rash on chest and back, very pruritic was recovering.  Information on the lot/batch number has been requested
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vertigo, Vomiting
Clinical narrative: Vertigo four days after vaccine, with no other symptoms until the vertigo started; The vertigo can be described as dizziness and nausea when moving head, which resulted in vomiting; The vertigo can be described as dizziness and nausea when moving head, which resulted in vomiting; The vertigo can be described as dizziness and nausea when moving head, which resulted in vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 13-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 24May2021 at 13:00 (at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Concomitant medications were not reported. The patient previously taken drug name was reported as no.  On 28May2021 at 09:00, the patient experienced vertigo four days after vaccine, with no other symptoms until the vertigo started, the vertigo can be described as dizziness and nausea when moving head, which resulted in vomiting. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of vertigo, dizziness, nausea and vomiting and included treatment with PHENERGAN and BENADRYL from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events vertigo four days after vaccine, with no other symptoms until the vertigo started, the vertigo can be described as dizziness and nausea when moving head, which resulted in vomiting was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Fatigue, Headache, Pyrexia
Clinical narrative: Light fever; Sore joints; Headache; Fatigue; High blood pressure; Severe rash; Severe rash or hives; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04May2021 at 07:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 04May2021 at 15:45, the patient experienced fever, sore joints, headache, fatigue, high blood pressure and severe rash or hives. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events light fever, sore joints, headache, fatigue, high blood pressure and severe rash or hives were resolving at the time of reporting.   Information on lot/batch number has been requested
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Light fever; Sore joints; Headache; Fatigue; High blood pressure; Severe rash; Severe rash or hives; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 04May2021 at 07:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19.  The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 04May2021 at 15:45, the patient experienced fever, sore joints, headache, fatigue, high blood pressure and severe rash or hives. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events light fever, sore joints, headache, fatigue, high blood pressure and severe rash or hives were resolving at the time of reporting.   Information on lot/batch number has been requested
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Inappropriate schedule of product administration, Oropharyngeal pain, Vomiting
Clinical narrative: Vomiting; Hacking cough; Sore throat; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 27May2021 at 11:45 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes, high cholesterol, high blood pressure and cat scan dye allergy. Concomitant medication included first dose of varicella herpes zoster vaccine (MANUFACTURER UNKNOWN) received on an unknown date in Apr2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 13May2021 at 11:45 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. The patient previously took phenobarbital (MANUFACTURER UNKNOWN), phenytoin (DILANTIN) and mesuximide (CELONTIN); all on unknown dates for unspecified indications and experienced drug allergy. The patient received other vaccine within four weeks prior to the vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. On 27May2021 at 17:00, the patient experienced vomiting, hacking cough and sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vomiting, hacking cough and sore throat were resolving at the time of reporting.   Information on lot/batch number has been requested
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Diarrhoea, Flatulence, Limb discomfort, Pain in extremity
Clinical narrative: Dehydration; left arm pain; unable to roll or lift on left arm; diarrhea; gas; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 29May2021 at 09:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not know about her other medical history. The patient was allergic to walnuts. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021, the patient experienced dehydration, left arm pain, unable to roll or lift on left arm, diarrhea and gas. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events dehydration, left arm pain, unable to roll or lift on left arm, diarrhea and gas were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Pruritus, Thermal burn
Clinical narrative: I developed burning; itching; blisters under and close to my right eye; shingles infection; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in Left arm on 27May2021 at 10:30 (at the age of 45 years) as single dose for COVID-19 immunisation. Medical history included fibromyalgia, chronic fatigue syndrome, pcos. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. Concomitant medication included metformin (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) from an unknown date and for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27May2021 at 15:00, patient experienced burning, itching, blisters under and close to right eye and shingles infection. The patient received any treatment for the reported events, filled anti-viral prescription. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event burning, itching, blisters under and close to right eye and shingles infection were recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss if taste; This is a spontaneous report from a contactable consumer. A 47-year-old female patient received second dose of bnt162b2 (BNT162B2, Solution for injection), via intramuscular, administered in Arm Left on 28May2021 (Batch/Lot number was not reported) as, single dose for covid-19 immunisation. Medical history included hypothyroidism and shellfish. The patent historical vaccine for COVID-19 immunization was on 01May2021 at the age of 47-year-old (Dose: 1, Lot no: EW0182, Route: Intramuscular, Anatomical location: Left Arm). Concomitant medication included levothyroxine sodium (SYNTHROID); ibuprofen (EXCEDRIN IB). On 29May2021, the patient experienced loss if taste. The outcome of the event was recovered on May2021.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site rash, Vaccination site swelling
Clinical narrative: COVID ARM large swollen rash around injection site; COVID ARM large swollen rash around injection site; Dose 1: 12May2021; Dose 2: 26May2021; This is a spontaneous report from contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP7534) via an unspecified route of administration in the arm left on 26May2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included doxycycline (ORACEA) since an unknown date taken within two weeks of vaccination for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the left arm on 12May2021 at 12:00 as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29May2021, the patient experienced "COVID ARM" large swollen rash around injection site. The patient did not receive any treatment for the event. The event had not resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event "COVID ARM" large swollen rash around injection site was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Late menstrual period; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the right arm on 30Apr2021 at 13:30 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 13:30(at the age of 20-year-old) as a single dose for COVID-19 immunisation. On 25May2021 at 00:00 the patient experienced late menstrual period, which is not typical for the patient. Therapeutic measures were not taken as a result of the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event late menstrual period was unknown at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Synovial cyst
Clinical narrative: Noticed a ganglion on the collar bone, noticed another one right under chin; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0183) via an unspecified route of administration in the arm left on 22May2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, the patient experienced a ganglion on the collar bone and on 28May2021, the patient noticed another one right under chin. The patient did not receive any treatment for the reported events. On 28May2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. The clinical outcome of the event ganglion on the collar bone and another one right under chin was not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16May2021 at 12:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ciclosporin (RESTASIS), ethinylestradiol, drospirenone (YASMIN), multivitamin (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and melatonin (MELATON); all from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 25Apr2021 at 12:00 as a single dose for COVID-19 immunisation and took Amoxicillin and Erythromycin; on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021 at 09:00, a week after second dose, the patient experienced Diarrhea and continues several times per day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event Diarrhea was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Ocular hyperaemia, Pyrexia
Clinical narrative: Feel like nauseated; Eyes starting to be blood shot; Extreme tired/Third day a little better but still a bit offatigue.; Feel having fever; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 11May2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had known allergies to acetaminophen. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 20:00, after the vaccination, the patient felt having fever. The patient was fine on the next morning before going to work. On 12May2021 at 07:00, the patient felt like nauseated and her eyes started to be blood shot. On 12May2021, the patient went home and slept almost all day, woke up to eat and went back to bed for hours. Next day the patient experienced same extreme tired and felt having fever but when checked, it was nothing. Third day, on 14May2021, the patient was a little better but still had a bit of fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event fever which included treatment with advil since the patient was allergic to acetaminophen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, felt like nauseated and eyes starting to be blood shot was resolved on an unknown date in May2021; while that of the extreme tired/fatigue was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Lethargy, Nausea, Pain
Clinical narrative: fever; chills; aching; nausea; lethargy; Flu like side effects set in 12 hours after 2nd dose.; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the arm left on 26Apr2021 at 12:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 00:00 the patient experienced Flu like side effects set in 12 hours after 2nd dose. On 27Apr2021 at 12:00 (24 hours after symptoms began) the patient experienced fever, chills, aching, nausea and lethargy. Felt 100% recovered within 36 hours of vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event.  The clinical outcome of the event flu like side effects, fever, chills, aching, nausea and lethargy was recovered on 27Apr2021.  No follow-up attempts are possible. No further information is expected
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; chills; aching; nausea; lethargy; Flu like side effects set in 12 hours after 2nd dose.; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the arm left on 26Apr2021 at 12:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 00:00 the patient experienced Flu like side effects set in 12 hours after 2nd dose. On 27Apr2021 at 12:00 (24 hours after symptoms began) the patient experienced fever, chills, aching, nausea and lethargy. Felt 100% recovered within 36 hours of vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event.  The clinical outcome of the event flu like side effects, fever, chills, aching, nausea and lethargy was recovered on 27Apr2021.  No follow-up attempts are possible. No further information is expected
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site rash
Clinical narrative: Rash on left arm at injection site 7 days after first dose; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021 the patient experienced rash on left arm at injection site 7 days after first dose. On an unknown date, the patient underwent nasal swab SARS Cov-2 test and the result was Unknown. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the event rash on left arm at injection site was recovered on unknown date in 2021 after 5 days of first dose before fading.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dry mouth, Fatigue, Pyrexia, Thirst
Clinical narrative: Bladder incontinence; Increased thirst; Dry mouth; Decreased appetite; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 27May2021 at 15:15 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included thalassemia minor and congenital pilonidal cyst. The patient did not have any allergies to medications, food or other products. Concomitant medication included ZYRTEC from an unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 06May2021 at 14:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021 at 02:30, the patient experienced bladder incontinence beginning 12 hours after injection and subsiding after approximately 12 hours, fatigue for more than 48 hours, dry mouth for more than 48 hours, increased thirst for approximately 36 hours, decreased appetite for more than 48 hours and fever beginning approximately 24 hours after injection and subsiding within 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event increased thirst was resolved on an unknown date in May2021. The clinical outcome of the events bladder incontinence, fatigue, dry mouth, decreased appetite,  and fever were resolving at the time of reporting.   Information on lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary incontinence
Clinical narrative: Bladder incontinence; Increased thirst; Dry mouth; Decreased appetite; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 27May2021 at 15:15 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history included thalassemia minor and congenital pilonidal cyst. The patient did not have any allergies to medications, food or other products. Concomitant medication included ZYRTEC from an unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 06May2021 at 14:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021 at 02:30, the patient experienced bladder incontinence beginning 12 hours after injection and subsiding after approximately 12 hours, fatigue for more than 48 hours, dry mouth for more than 48 hours, increased thirst for approximately 36 hours, decreased appetite for more than 48 hours and fever beginning approximately 24 hours after injection and subsiding within 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event increased thirst was resolved on an unknown date in May2021. The clinical outcome of the events bladder incontinence, fatigue, dry mouth, decreased appetite,  and fever were resolving at the time of reporting.   Information on lot/batch number has been requested.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site bruising, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: About 48 hours after the vaccine, the injection site began to itch as well; Injection site bruising; Injection site bruising, redness, and swelling within an area about two inches in diameter.; Injection site bruising, redness, and swelling within an area about two inches in diameter.; General arm soreness over the next couple days; Tenderness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28May2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), hydroxyzine (MANUFACTURER UNKNOWN) and methylphenidate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021, the patient experienced injection site bruising, redness, swelling within an area about two inches in diameter, general arm soreness over the next couple days and tenderness at the injection site. On 30May2021, about 48 hours after the vaccination, the patient experienced injection site began to itch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events injection site bruising, redness, swelling within an area about two inches in diameter, general arm soreness, tenderness at the injection site and injection site began to itch was not resolved at the time of this report.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: About 48 hours after the vaccine, the injection site began to itch as well; Injection site bruising; Injection site bruising, redness, and swelling within an area about two inches in diameter.; Injection site bruising, redness, and swelling within an area about two inches in diameter.; General arm soreness over the next couple days; Tenderness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28May2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), hydroxyzine (MANUFACTURER UNKNOWN) and methylphenidate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021, the patient experienced injection site bruising, redness, swelling within an area about two inches in diameter, general arm soreness over the next couple days and tenderness at the injection site. On 30May2021, about 48 hours after the vaccination, the patient experienced injection site began to itch. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events injection site bruising, redness, swelling within an area about two inches in diameter, general arm soreness, tenderness at the injection site and injection site began to itch was not resolved at the time of this report.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: Since getting the 2nd shot I have been fatigued and have had dizzy spells.; Since getting the 2nd shot I have been fatigued and have had dizzy spells.; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0165) via an unspecified route of administration in the left arm on 10May2021 at 09:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation. Concomitant medications included flecainide (MANUFACTURER UNKNOWN)  and metoprolol (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 08:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14May2021, since getting the second shot the patient felt fatigued and had dizzy spells. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the fatigued and dizzy spells was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hot flush
Clinical narrative: Continuing hot flashes; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 24May2021 at 18:15 as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously took AMOX and experienced a drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26May2021, the patient experienced continuing hot flashes which occurred when the patient was physically active; example while cleaning, walking et cetera. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event continuing hot flashes was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Headache; Nausea; Vomiting; Fever; Muscle pain; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24May2021 at 14:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021, the patient experienced headache, nausea, vomiting, fever, muscle pain, tiredness. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, vomiting, fever, muscle pain, tiredness was recovered on an unknown date in May2021.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache; Nausea; Vomiting; Fever; Muscle pain; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24May2021 at 14:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021, the patient experienced headache, nausea, vomiting, fever, muscle pain, tiredness. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, vomiting, fever, muscle pain, tiredness was recovered on an unknown date in May2021.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Large rash all over back; This is a spontaneous report from a non-contactable consumer, the patient. A 71-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date the patient experienced large rash all over back for a month after vaccination. The clinical outcome of the event large rash all over back was unknown at the time of report.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms, Pyrexia
Clinical narrative: 3 to 4 days experienced fatigue; Low grade fever; Experienced ongoing intermittent cramping in legs; Experienced ongoing intermittent cramping in arms; Cramping in all areas of the body; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in Left deltoid on 29Apr2021 at 16:00 as single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications were reported. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04May2021 at 03:45, patient experienced fatigue, low grade fever, cramping in legs, arms, and cramping in body. No therapeutic measures were taken as a result of reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event fatigue, low grade fever, cramping in legs, arms, and cramping in body were not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.